Incidence of glaucoma in patients with systemic lupus erythematosus: a nationwide cohort study in South Korea

Systemic Lupus Erythematosus

Kidney outcomes of systemic lupus erythematosus patients treated with SGLT2 inhibitors: A national cohort study

Semin Arthritis Rheum

Sagy I, Shitrit I, Abuhasira R, David RB, Haviv YS, Tayer-Shifman O, Abu-Shakra M, Brav E, Burrack N, Zeller L

doi: 10.1016/j.semarthrit.2025.152746

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Systemic Lupus Erythematosus

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

Semin Arthritis Rheum

Ibarguengoitia-Barrena O, Riancho-Zarrabeitia L, Plaza Z, Rúa-Figueroa Í, Roberts K, Martínez-Taboada V, Menor-Almagro R, Serrano-Benavente B, Rubio-Muñoz P, Galindo-Izquierdo M, Fernández-Nebro A, Ruiz-Lucea ME, Calvo-Alén J, Tomero-Muriel EG, Uriarte-Isacelaya E, Pecondon-Españo A, Freire M, García-Fernández J, Expósito L, Ibañez-Barceló M, Aurrecoechea E, Montilla C, Rosas-Gómez de Salazar J, García-Villanueva MJ, Caño-Alameda R, Toyos-Sáenz de Miera FJ, Nóvoa-Medina FJ, Moriano-Morales C, Bonilla G, Narváez FJ, Andréu JL, Arévalo-Salaet M, Horcada L, Cobo T, Lozano-Rivas N, Bohorquez C, Iñíguez-Ubiaga CL, Salgado-Perez E, Torrente-Segarra V, Salman Monte TC, Oller JE, Pego-Reigosa JM, RELESSER research group

doi: 10.1016/j.semarthrit.2025.152819

Systemic Lupus Erythematosus

Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study

Rheumatology (Oxford)

Miyake H, Kida T, Yoshimi R, Michizu Y, Nishimura K, Sada KE, Miyawaki Y, Matsuo Y, Ohno S, Kajiyama H, Sato S, Shimojima Y, Fujiwara M, Takatani A, Onishi T, Katsushima M, Ida T, Umekita K, Nakano H, Ikeda K, Ichinose K, Onishi A

doi: 10.1093/rheumatology/keaf504

Systemic Lupus Erythematosus

Trust in Health Information Sources Among Patients with Systemic Lupus Erythematosus in the Social Networking Era: The TRUMP(2)-SLE Study

J Rheumatol

Ichikawa T, Kishida D, Shimojima Y, Yajima N, Oguro N, Yoshimi R, Sakurai N, Hidekawa C, Sada KE, Miyawaki Y, Hayashi K, Shidahara K, Ishikawa Y, Sekijima Y, Kurita N

doi: 10.3899/jrheum.2024-1088

Systemic Lupus ErythematosusSystemic Sclerosis

Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Rheumatology (Oxford)

Patasova K, Dehara M, Mantel Ä, Bixo M, Arkema E, Holmqvist M

doi: 10.1093/rheumatology/keaf004

Systemic Lupus Erythematosus

Individual and Socio-ecological Resilience in Childhood-Onset Systemic Lupus Erythematosus: Associations with Patient Characteristics and Psychosocial Patient-Reported Outcomes

J Rheumatol

Zaffino I, Boulard L, Law J, Danguecan A, Jeyanathan A, Ng L, Williams-Reid S, Reid K, Cortes A, Cortes E, Levy DM, Hiraki LT, Knight AM

doi: 10.3899/jrheum.2025-0375

Systemic Lupus Erythematosus

Interstitial lung disease in systemic lupus erythematosus: a 30-year population study

Rheumatology (Oxford)

Ng DM, Keen HI, Preen DB, Inderjeeth CA, Nossent JC

doi: 10.1093/rheumatology/keaf597

Systemic Lupus Erythematosus

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open-Label Trial

Arthritis Care Res (Hoboken)

Brunner HI, Antón J, Calvo-Penadés I, Dimelow R, Horneff G, Kamphuis S, Marino R, van Maurik A, Minden K, Mori M, Ocran-Appiah J, Wilkinson C, Yamasaki Y, Assudani D, Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) network investigators

doi: 10.1002/acr.25700

Related content

Kidney outcomes of systemic lupus erythematosus patients treated with SGLT2 inhibitors: A national cohort study

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study

Trust in Health Information Sources Among Patients with Systemic Lupus Erythematosus in the Social Networking Era: The TRUMP(2)-SLE Study

Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Individual and Socio-ecological Resilience in Childhood-Onset Systemic Lupus Erythematosus: Associations with Patient Characteristics and Psychosocial Patient-Reported Outcomes

Interstitial lung disease in systemic lupus erythematosus: a 30-year population study

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open-Label Trial